Pfizer Inc. Earnings

Pfizer Inc.’s revenue fell -5.92% since last year same period to $16654Mn in the Q3 2025. On a quarterly growth basis, Pfizer Inc. has generated 13.66% jump in its revenue since last 3-months.

Pfizer Inc.’s net profit fell -20.84% since last year same period to $3541Mn in the Q3 2025. On a quarterly growth basis, Pfizer Inc. has generated 21.68% jump in its net profits since last 3-months.

Pfizer Inc.’s net profit margin fell -15.85% since last year same period to 21.26% in the Q3 2025. On a quarterly growth basis, Pfizer Inc. has generated 7.06% jump in its net profit margins since last 3-months.

Pfizer Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.56 - a -11.11% fall from last quarter’s estimates.

Pfizer Inc.’s earning per share (EPS) estimates for the current year stand at 0.56.

Pfizer Inc.’s earning per share (EPS) fell -17.92% since last year same period to 0.87 in the Q3 2025. This indicates that the Pfizer Inc. has generated -17.92% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Pfizer Inc. declared 0.43 dividend per share during the earnings announcement for Q3 2025.